These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9889620)

  • 1. [Therapeutic targets in the management of blood pressure are constant].
    Wensaas KA
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4413-4. PubMed ID: 9889620
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Too HOT" blood pressure?].
    Klovning A; Sandvik H; Straand J
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):3005. PubMed ID: 9748845
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin for hypertension?
    Harv Mens Health Watch; 2007 Jul; 11(12):7-8. PubMed ID: 17687796
    [No Abstract]   [Full Text] [Related]  

  • 4. [How much should arterial pressure figures be lowered with treatment? Reflections after the HOT (Hypertension Optimal Treatment) study].
    Coca A; Ruilope LM
    Med Clin (Barc); 1999 Jun; 113(1):20-2. PubMed ID: 10422073
    [No Abstract]   [Full Text] [Related]  

  • 5. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
    Waeber B; Mourad JJ
    Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should blood pressure be regulated during the acute phase of apoplexy?].
    Andersen G
    Ugeskr Laeger; 2002 Mar; 164(11):1477-9. PubMed ID: 11924469
    [No Abstract]   [Full Text] [Related]  

  • 8. [Three comments on the LIFE trial].
    Rastad JA
    Lakartidningen; 2002 May; 99(18):2090. PubMed ID: 12082791
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

  • 10. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The HOT-debate, and so what?].
    Dyrdal A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):999-1000. PubMed ID: 10210965
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evidence-based treatment of hypertension in type 2-diabetes. New studies support active blood pressure reduction].
    Nilsson P
    Lakartidningen; 2000 Feb; 97(6):568-72. PubMed ID: 10707481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension: treatment--now & tomorrow.
    Nzerue CM
    Ethn Dis; 2002; 12(1):S2-43-5. PubMed ID: 11913641
    [No Abstract]   [Full Text] [Related]  

  • 14. Care management shows benefits.
    Dis Manag Advis; 2008 Aug; 14(8):suppl 1-4, 1, following p. 6. PubMed ID: 18771042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E
    Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
    Conlin PR
    Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of outcome trials in providing information on antihypertensive treatment: importance and limitations.
    Mancia G
    Am J Hypertens; 2006 Jan; 19(1):1-7. PubMed ID: 16461181
    [No Abstract]   [Full Text] [Related]  

  • 20. Aliskiren: a novel renin inhibitor for hypertension.
    Parmar DM; Jadav SP
    Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.